Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran

Publisher： Karger

E-ISSN： 1662-680x|8|3|224-228

ISSN： 1662-680x

Source： Case Reports in Neurology, Vol.8, Iss.3, 2016-10, pp. : 224-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatal Intracerebral Hemorrhage Associated with Administration of Recombinant Tissue Plasminogen Activator in a Stroke Patient on Treatment with Dabigatran

By  

Cerebrovascular Diseases, Vol. 32, Iss. 6, 2011-12 ,pp. : 614-615

Karger

Access to resources Recommend Favorite

Stroke Prenotification Is Associated with Shorter Treatment Times for Warfarin-Associated Intracerebral Hemorrhage

By  

Cerebrovascular Diseases, Vol. 36, Iss. 5-6, 2013-11 ,pp. : 383-387

Karger

Access to resources Recommend Favorite

Intracerebral Hemorrhage: Outcomes and Eligibility for Factor VIIa Treatment in a National Stroke Registry

By  

Cerebrovascular Diseases, Vol. 22, Iss. 4, 2006-08 ,pp. : 271-275

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report

By  

Case Reports in Neurology, Vol. 8, Iss. 2, 2016-06 ,pp. : 140-144

Karger

Access to resources Recommend Favorite

Is There a Penumbra Surrounding Intracerebral Hemorrhage?

By  

Cerebrovascular Diseases, Vol. 23, Iss. 1, 2006-10 ,pp. : 4-5

Karger

Access to resources Recommend Favorite